EPIVAC
EPIVAC (Epidemiologia i Vacunes)

RESPONSABLE DEL GRUP
avatar_investigadors.jpg
Cinta de Diego Cabanes
mcdiego.tgn.ics@gencat.cat
avatar_grups_recerca.png

Publicacions

Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain

E. SATUE-GRACIA, A. VILA-COORCOLES, C. DE DIEGO-CABANES, A. VILA-ROVIRA, C. TORRENTE-FRAGA, F. GOMEZ-BERTOMEU, I. HOSPITAL-GUARDIOLA, O. OCHOA-GONDAR and F. MARTIN-LUJAN
MEDICINA CLINICA. 2022 Mar 18; . doi:10.1016/j.medcli.2021.03.027; PMID:34074472

Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination among adults with immunocompromising conditions

E. SATUE-GRACIA, C. CABANES, A. VILA-ROVIRA, C. RODRIGUEZ-CASADO, O. OCHOA-GONDAR and A. VILA-CORCOLES
EUROPEAN RESPIRATORY JOURNAL. 2022 Sep 4; . doi:10.1183/13993003.congress-2022.263;

COVID-19 prognostic indicators in Primary Care

E. GRACIA and A. CORCOLES
ATENCION PRIMARIA. 2022 Jul 1; . doi:10.1016/j.aprim.2022.102308; PMID:35306295

Pneumococcal vaccination in times of COVID-19

A. CORCOLES
MEDICINA CLINICA. 2022 Apr 22; . doi:10.1016/j.medcli.2022.01.001; PMID:35177267

Pneumococcal vaccination in times of COVID-19.

Vila Córcoles Á
Medicina Clinica (english Ed.). 2022 May 5; . doi:10.1016/j.medcle.2022.01.004; PMID:35530263

Patronat

Col·laboradors

Acreditacions